These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29768914)

  • 41. Fluorescence polarization-based assays for detecting compounds binding to inactive c-Jun N-terminal kinase 3 and p38α mitogen-activated protein kinase.
    Ansideri F; Lange A; El-Gokha A; Boeckler FM; Koch P
    Anal Biochem; 2016 Jun; 503():28-40. PubMed ID: 26954235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graph-Based Clustering of Predicted Ligand-Binding Pockets on Protein Surfaces.
    Degac J; Winter U; Helms V
    J Chem Inf Model; 2015 Sep; 55(9):1944-52. PubMed ID: 26325445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha.
    Ge B; Gram H; Di Padova F; Huang B; New L; Ulevitch RJ; Luo Y; Han J
    Science; 2002 Feb; 295(5558):1291-4. PubMed ID: 11847341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modeling the binding affinity of p38α MAP kinase inhibitors by partial least squares regression.
    Basant N; Durante C; Cocchi M; Menziani MC
    Chem Biol Drug Des; 2012 Sep; 80(3):455-70. PubMed ID: 22642504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two-dimensional replica-exchange method for predicting protein-ligand binding structures.
    Kokubo H; Tanaka T; Okamoto Y
    J Comput Chem; 2013 Nov; 34(30):2601-14. PubMed ID: 24006253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implications of the small number of distinct ligand binding pockets in proteins for drug discovery, evolution and biochemical function.
    Skolnick J; Gao M; Roy A; Srinivasan B; Zhou H
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1163-70. PubMed ID: 25690787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design.
    Liang J; Edelsbrunner H; Woodward C
    Protein Sci; 1998 Sep; 7(9):1884-97. PubMed ID: 9761470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computational Analysis of Sterol Ligand Specificity of the Niemann Pick C2 Protein.
    Poongavanam V; Kongsted J; Wüstner D
    Biochemistry; 2016 Sep; 55(36):5165-79. PubMed ID: 27533706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moving Beyond Active-Site Detection: MixMD Applied to Allosteric Systems.
    Ghanakota P; Carlson HA
    J Phys Chem B; 2016 Aug; 120(33):8685-95. PubMed ID: 27258368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modified replica exchange simulation methods for local structure refinement.
    Cheng X; Cui G; Hornak V; Simmerling C
    J Phys Chem B; 2005 Apr; 109(16):8220-30. PubMed ID: 16851961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Application of Ligand-Mapping Molecular Dynamics Simulations to the Rational Design of Peptidic Modulators of Protein-Protein Interactions.
    Tan YS; Spring DR; Abell C; Verma CS
    J Chem Theory Comput; 2015 Jul; 11(7):3199-210. PubMed ID: 26575757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting locations of cryptic pockets from single protein structures using the PocketMiner graph neural network.
    Meller A; Ward M; Borowsky J; Kshirsagar M; Lotthammer JM; Oviedo F; Ferres JL; Bowman GR
    Nat Commun; 2023 Mar; 14(1):1177. PubMed ID: 36859488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular dynamics simulations of biological membranes and membrane proteins using enhanced conformational sampling algorithms.
    Mori T; Miyashita N; Im W; Feig M; Sugita Y
    Biochim Biophys Acta; 2016 Jul; 1858(7 Pt B):1635-51. PubMed ID: 26766517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a rule-based method for the assessment of protein druggability.
    Perola E; Herman L; Weiss J
    J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Niemann-Pick type C disease: importance of N-glycosylation sites for function and cellular location of the NPC2 protein.
    Chikh K; Vey S; Simonot C; Vanier MT; Millat G
    Mol Genet Metab; 2004 Nov; 83(3):220-30. PubMed ID: 15542393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strong and weak zinc binding sites in human zinc-α2-glycoprotein.
    Kumar AA; Hati D; Thaker TM; Miah L; Cunningham P; Domene C; Bui TT; Drake AF; McDermott LC
    FEBS Lett; 2013 Dec; 587(24):3949-54. PubMed ID: 24188824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knowledge-guided docking: accurate prospective prediction of bound configurations of novel ligands using Surflex-Dock.
    Cleves AE; Jain AN
    J Comput Aided Mol Des; 2015 Jun; 29(6):485-509. PubMed ID: 25940276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors.
    Drinkwater N; Vu H; Lovell KM; Criscione KR; Collins BM; Prisinzano TE; Poulsen SA; McLeish MJ; Grunewald GL; Martin JL
    Biochem J; 2010 Oct; 431(1):51-61. PubMed ID: 20642456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A screening system for the identification of refolding conditions for a model protein kinase, p38alpha.
    Cowan RH; Davies RA; Pinheiro TT
    Anal Biochem; 2008 May; 376(1):25-38. PubMed ID: 18294951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors.
    Astolfi A; Iraci N; Manfroni G; Barreca ML; Cecchetti V
    ChemMedChem; 2015 Jun; 10(6):957-69. PubMed ID: 26012502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.